Asia Medical and Agricultural Laboratory and Research Center Public Company Limited carries a market capitalization of 1.47B, placing it among publicly traded companies globally. Its enterprise value stands at 1.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.47B |
| Enterprise Value | 1.27B |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited currently has 414.97M shares outstanding.
| Shares Outstanding | 414.97M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited trades at a trailing price-to-earnings ratio of 8.98. The price-to-sales ratio is 2.88, and the price-to-book ratio stands at 4.51.
| PE Ratio | 8.98 |
| PS Ratio | 2.88 |
| PB Ratio | 4.51 |
| P/TBV Ratio | 2.42 |
| P/FCF Ratio | 5.71 |
| P/OCF Ratio | 7.06 |
On an enterprise value basis, Asia Medical and Agricultural Laboratory and Research Center Public Company Limited trades at an EV/EBITDA multiple of 6.38 and an EV/FCF ratio of 5.08. The EV/Sales ratio of 2.57 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.08 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.57 |
| EV / EBITDA | 6.38 |
| EV / EBIT | 8.08 |
| EV / FCF | 5.08 |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited maintains a current ratio of 5.09, meaning it holds 5.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.03, indicating elevated leverage, while an interest coverage ratio of 245.89 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.09 |
| Quick Ratio | 4.74 |
| Debt / Equity | 3.03 |
| Debt / EBITDA | 0.09 |
| Interest Coverage | 245.89 |
| Return on Equity (ROE) | 55.15 |
| Return on Assets (ROA) | 23.34 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 18.37 |
| Income Tax | -1.97M |
| Effective Tax Rate | N/A |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited's stock has gained approximately 56.52174% over the past 52 weeks. The 50-day moving average sits at 3.63, while the 200-day moving average is 3.17.
| Beta (5Y) | N/A |
| 52-Week Price Change | 56.52174% |
| 50-Day Moving Average | 3.63 |
| 200-Day Moving Average | 3.17 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Asia Medical and Agricultural Laboratory and Research Center Public Company Limited generated 493.10M in revenue and converted that into 157.84M in net income, yielding earnings per share of 0.38. EBITDA reached 198.37M, while operating income came in at 156.68M.
| Revenue | 493.10M |
| Gross Profit | 264.24M |
| Operating Income | 156.68M |
| Pretax Income | 155.87M |
| Net Income | 157.84M |
| EBITDA | 198.37M |
| EBIT | 156.68M |
| Earnings Per Share (EPS) | 0.38 |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited holds 170.19M in cash and equivalents against 18.42M in total debt, resulting in a net debt position of -120.19M. Total book value stands at 314.12M, with working capital of 200.38M providing operational flexibility.
| Cash & Cash Equivalents | 170.19M |
| Total Debt | 18.42M |
| Net Debt | -120.19M |
| Equity (Book Value) | 314.12M |
| Book Value Per Share | 0.75 |
| Working Capital | 200.38M |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited produced 200.74M in operating cash flow over the past twelve months. After subtracting -47.73M in capital expenditures, free cash flow totaled 153.01M - equivalent to 0.36 per share.
| Operating Cash Flow | 200.74M |
| Capital Expenditures | -47.73M |
| Free Cash Flow | 153.01M |
| FCF Per Share | 0.36 |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited operates with a gross margin of 53.59, reflecting its pricing power and cost economics. The operating margin of 31.77 and net profit margin of 32.01 provide insight into operational efficiency.
| Gross Margin | 53.59 |
| Operating Margin | 31.77 |
| Pretax Margin | 31.61 |
| Profit Margin | 32.01 |
| EBITDA Margin | 40.23 |
The company's payout ratio of 45.22 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.17 |
| Dividend Yield | N/A |
| Payout Ratio | 45.22 |
| Shareholder Yield | 7.72 |
| FCF Yield | 17.52 |
Asia Medical and Agricultural Laboratory and Research Center Public Company Limited posts an Altman Z-Score of 10.94, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.94 |